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Abstract
Background: Neutrophils depend mainly on glycolysis for their energy provision. Their mitochondria maintain a membrane
potential (Dym), which is usually generated by the respiratory chain complexes. We investigated the source of Dym in
neutrophils, as compared to peripheral blood mononuclear leukocytes and HL-60 cells, and whether neutrophils can still
utilise this Dym for the generation of ATP.
Methods and Principal Findings: Individual activity of the oxidative phosphorylation complexes was significantly reduced
in neutrophils, except for complex II and V, but Dym was still decreased by inhibition of complex III, confirming the role of
the respiratory chain in maintaining Dym. Complex V did not maintain Dym by consumption of ATP, as has previously been
suggested for eosinophils. We show that complex III in neutrophil mitochondria can receive electrons from glycolysis via the
glycerol-3-phosphate shuttle. Furthermore, respiratory supercomplexes, which contribute to efficient coupling of the
respiratory chain to ATP synthesis, were lacking in neutrophil mitochondria. When HL-60 cells were differentiated to
neutrophil-like cells, they lost mitochondrial supercomplex organisation while gaining increased aerobic glycolysis, just like
neutrophils.
Conclusions: We show that neutrophils can maintain Dym via the glycerol-3-phosphate shuttle, whereby their mitochondria
play an important role in the regulation of aerobic glycolysis, rather than producing energy themselves. This peculiar
mitochondrial phenotype is acquired during differentiation from myeloid precursors.
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Introduction
Neutrophils are the main phagocytic cells of the human
immune system. These cells are the first to arrive at a site of
infection, where they kill ingested microorganisms by producing
superoxide through a rapid, NADPH (nicotinamide adenine
dinucleotide phosphate, reduced) oxidase-mediated, respiratory
burst, in combination with an arsenal of proteolytic enzymes and
anti-microbial peptides [1,2]. Neutrophils derive most of the
energy required for these and other functions from a high rate of
glycolysis [3]. This ensures that neutrophils can function in an
inflammatory environment where the oxygen tension may be low
or even absent [3–5].
Neutrophils contain relatively few mitochondria, which form a
complex network inside the cell [6,7]. It has been assumed that
these organelles do not produce energy by respiration, as they do
in other cells [3,6]. However, neutrophil mitochondria can be
stained with various mitochondria-specific dyes and do maintain a
transmembrane potential (Dym), which is normally associated with
respiratory chain activity and oxidative phosphorylation (OX-
PHOS) of adenosine diphosphate (ADP) [6,7].
Dym is generated by a series of four protein complexes (complex
I-IV, respectively) in the mitochondrial inner membrane, which
transfer electrons derived from the oxidation of reduced nicotin-
amide adenine dinucleotide (NADH) by complex I (NADH-
ubiquinone oxidoreductase) or from the oxidation of succinate by
complex II (succinate-ubiquinone oxidoreductase). Complex I,
complex III (ubiquinol-cytochrome c oxidoreductase) and complex
IV (cytochrome c oxidase) are the proton exchangers that maintain
Dym by transferring electrons to a subsequent complex or to
molecular oxygen, with a concomitant transfer of protons out of the
mitochondrial matrix. The final complex of the OXPHOS
machinery, complex V (F1/F0-ATPase), is a very efficient molecular
motor that allows the protons to flow back through its subunit F0
while utilizing the proton gradient for the phosphorylation of ADP
to adenosine triphosphate (ATP) in the F1 subunit [8,9].
PLoS ONE | www.plosone.org 1 April 2008 | Volume 3 | Issue 4 | e2013Dym can also be maintained by the adenosine nucleotide
transporter (ANT) in collaboration with complex V. ANT is
responsible for transporting ADP into the mitochondrial matrix in
exchange for ATP. However, in the absence of respiration, ANT
can transport ATP
42 into the matrix in exchange for ADP
32 and
thus maintain Dym by a net influx of negative charges [9–12]. This
mechanism is only functional if the F1-ATPase provides the
necessary ADP by hydrolysing ATP, but it is independent of the
proton exchanger F0.
Recent evidence has indicated that respiratory chain complexes
can be organized in larger supercomplexes in the mitochondrial
inner membrane [13–17]. Supercomplexes of different composition
have been described in various organisms, including yeast and
mammals[18,19]. Inbovineheartandhumanskeletalmuscle,these
supercomplexes appear to be composed of a complex I monomer, a
complex III dimer and up to four copies of complex IV,
representing the largest forms of OXPHOS complex assemblies,
also termed ‘respirasomes’ [14,15,17,20]. The inclusion of complex
IV in the supercomplex significantly enhances the activity of
complex I and complex III [13,14]. Thus, the efficiency of electron
transfer along the respiratory chain is largely dependent on the
composition of these respiratory supercomplexes.
Resting neutrophils consume little or no oxygen, and classical
inhibitors of respiration, such as cyanide (KCN), an inhibitor of
complex IV, do not affect neutrophil functions [3,6]. In addition,
neutrophil mitochondria contain very little cytochrome c, which
would indicate a very low complex IV content and inefficient
respiration [6,21]. However, prolonged incubation with oligomycin
(longer than 2 hours), an inhibitor of the F0-ATPase of the
respiratory chain, does affect both NADPH oxidase activity and
neutrophil chemotaxis [7]. This suggests that complex V is active
and may play an important role in maintaining neutrophil functions.
In this report, we investigated how neutrophils maintain Dym
and whether their mitochondria still play a role in the regulation of
their energy metabolism. We show that Dym in neutrophils is
maintained by residual respiratory chain activity, even though this
activity is apparently hardly coupled to ADP phosphorylation. In
addition, we show that the respiratory chain complexes in
neutrophils lack supercomplex organisation, while these super-
complexes are present in peripheral blood mononuclear cells
(PBMC) and the myeloid cell line HL-60. During differentiation to
neutrophil-like cells, HL-60 cells loose mitochondrial super-
complex organisation, while gaining neutrophil-like abilities. We
suggest that the lack of mitochondrial supercomplex organisation
and the consequent lack of respiration is a requirement to
maintain a high rate of aerobic glycolysis in order to fulfil the
primary human neutrophil functions.
Results
Neutrophils retain some respiratory chain complex
activity
To establish whether the respiratory chain could be responsible
for maintaining Dym in neutrophils, we determined the activity of
the OXPHOS complexes in the isolated mitochondria of
neutrophils, PBMC, and HL-60 cells. Although the mitochondrial
content, as expressed by citrate synthase activity, was significantly
reduced in neutrophils as compared to the other cells (Figure 1A),
neutrophils still displayed respiratory chain enzyme activity.
Complex II and complex V (F1) displayed normal levels of
activity, while some complex I and complex III activity was
detected as well (Figure 1B). The activity of complex IV was
severely reduced in neutrophils as compared to the control cells.
These results are in line with the observation that neutrophil
mitochondria contain very little cytochrome c, an essential
component of complex IV [6,21].
Even though complex I, III and IV displayed very little
enzymatic activity, Western blotting showed the presence of the
cornerstone subunits of these complexes in neutrophil mitochon-
dria lysates, although the total amount of the OXPHOS proteins
that could be detected on blot was significantly less than in the
control cells (Figure 1C).
Respiratory chain complexes in neutrophil mitochondria
are not organised in supercomplexes
To visualise the organisation of the respiratory chain complexes
in neutrophils and the control cells, isolated mitochondria from
these cells were solubilised with digitonin before subjecting the
samples to blue native(BN)-PAGE. The BN-PAGE gels were
subsequently processed by denaturating SDS-PAGE to resolve the
(super)complexes into their respective subunits, before visualising
the essential subunit of each of the five OXPHOS complexes by
immunoblotting.
In PBMC, complex III appears to form three distinct
supercomplexes with complex IV of ,1.5 MDa, ,600 kDa and
,470 kDa (Figure 2A). Fully assembled complex I is only present
in the largest of these three supercomplexes (,1.5 MDa), but a
subcomplex of about 370 kDa of complex I in association with
complex IV is also demonstrable. Complex II is not present in any
supercomplex with the other respiratory chain complexes, as
expected. Complex V showed apparent molecular masses of
,1.5 MDa (dimer), ,600 kDa (monomer), 470 and 370 kDa (F1
subcomplexes), and even less (Figure 2A).
Complex III and complex IV appear outside any supercomplex
in neutrophils, having apparent molecular masses of ,230 and
,370 kDa, respectively (Figure 2B). The level of expression of
complex I and II was below the detection limit on the neutrophil
blot (Figure 2B). In neutrophils, complex V was present in four
super- and subcomplexes with molecular masses ranging from
1.5 MDa to 370 kDa, but the level of expression of these
complexes was significantly less than in PBMC.
Activity of complex III but not V is required for
maintaining Dym in neutrophil mitochondria
The fluorescent dye JC-1 (5,59,6,69-tetrachloro-1,19,3,39-tetra-
ethyl-imidacarbocyanine iodide) was used to determine Dym in
freshly prepared cells. JC-1 forms red fluorescent J-aggregates
when the positively charged dye accumulates at high concentra-
tion in functional mitochondria, while the monomeric form is
green fluorescent at lower concentrations. Thus, changes in the
ratio between the intensity of the red (Fl-2) to green (Fl-1)
fluorescence indicate changes in Dym.
Because complex V displayed normal activity in neutrophils and
represents the only remaining active complex capable of maintain-
ing Dym in neutrophil mitochondria, complex V was inhibited with
increasing concentrations of either the F0-ATPase inhibitor
oligomycin or the F1-ATPase inhibitor aurovertin B. No decrease
in Dym was observed in either neutrophils or PBMC (Figures 3A
and 3B). However, oligomycin did cause a collapse of Dym at
concentrations above 1 mM in both cell types, with or without
glucose. This is probably due to an aspecific effect of the inhibitor at
high concentrations in intact cells, since even the PBMC, which
have a normal respiratory chain, were affected. Generally, titration
with the complex V inhibitors induced a rise in Dym, as expected in
cells with respiring mitochondria. After all, complex V normally
lowers Dym by allowing protons to flow back into the mitochondrial
matrix along with the gradient produced by the other complexes.
Neutrophil Metabolism
PLoS ONE | www.plosone.org 2 April 2008 | Volume 3 | Issue 4 | e2013Figure 1. Mitochondrial content and respiratory chain enzyme activity in neutrophils, PBMC and HL-60 cells. A) Neutrophils (PMN)
contain significantly less mitochondria as expressed per unit citrate synthase activity. Data represent the mean (6SD) of 13 (PMN), 6 (HL-60) or 16
(PBMC) different experiments performed in duplicate. B) Neutrophils retain full complex II and V activity while the activity of the remaining
complexes is significantly reduced. Data represent the mean (6SD) of 10 different experiments performed in duplicate. Values were corrected for
mitochondrial protein content and citrate synthase activity. C) Crucial subunits of the respiratory chain can be detected in neutrophil lysates on
Western blot. 20 mg of mitochondrial protein was separated by SDS-PAGE and immuno-detected with anti-complex I (20 kDa), complex II (30 kDa),
complex III (Core 2, 47 kDa), complex IV (COX II, 26 kDa) and complex V (a, 55 kDa) subunit antibodies. Blots exposed for 15 sec and 5 minutes are
representative of three independent experiments.
doi:10.1371/journal.pone.0002013.g001
Neutrophil Metabolism
PLoS ONE | www.plosone.org 3 April 2008 | Volume 3 | Issue 4 | e2013Inhibition of complex III by antimycin A annihilated the Dym
in both cell types, with neutrophils slightly more sensitive to low
concentrations of this irreversible inhibitor than PBMC
(Figure 3C). The higher sensitivity of neutrophils to this inhibitor
can be explained by the fact that neutrophils contain relatively
small amounts of complex III as compared to PBMC
(Figure 2).This observation indicates that complex III, although
showing little cytochrome c-reducing activity in neutrophils, still
plays an important role in maintaining Dym in these cells.
Inhibition of complex I by titration of rotenone also reduced the
Dym in both neutrophils and PBMC in the absence of glucose,
although the inhibitory effect was larger in PBMC (Figure 3D). In
the presence of glucose, increasing concentrations of rotenone had a
slightly protective effect on Dym in neutrophils, whereas in PBMC
rotenone did reduce Dym, albeit not as pronounced as in the
absence of glucose. These diminished effects are probably due to a
combination of complex II activity compensating for the loss of
electron flux from complex I and of ATP hydrolysis by complex V.
Neutrophil mitochondria control lactate production but
hardly contribute to ATP levels
To investigate the role of respiratory chain enzyme activity in
maintaining the ATP levels of intact neutrophils and PBMC, cells
were incubated with or without 5 mM glucose in the presence of
increasing concentrations of specific OXPHOS inhibitors. After
2 hours of starvation, followed by a 2-hour incubation period with
the inhibitor, the cells were lysed and ATP and lactate levels were
determined in the neutralised lysates (Figures 4 and 5, respective-
ly).
ATP levels in the control cells, i.e. PBMC cultured without
glucose, proved particularly sensitive to the mitochondrial
uncoupler carbonyl cyanide 3-chlorophenylhydrazone (CCCP;
Figure 4A), to rotenone (Figure 4B), to antimycin A (Figure 4D)
and to aurovertin B (Figure 4F). These compounds affected the
ATP levels of the PBMC at a concentration of 100 nM or less.
The complex II inhibitor 3-nitropropionate (3NP, Figure 4C),
which was preferred over tenoyltrifluoroacetone (TTFA) in intact
cells owing to the aspecific effects of the latter (data not shown),
and the complex IV inhibitor KCN (Figure 4E) were only effective
in reducing the ATP levels of the PBMC at concentrations of
.100 mM. This is probably due to the hydrophilic nature of these
inhibitors.
In neutrophils, the ATP levels remained largely unaffected by
any of the inhibitors tested. Only CCCP (Figure 4A) caused a
complete loss of ATP in neutrophils at a concentration of 10 mM.
However, at this concentration the plasma membrane potential is
also affected by this uncoupling agent (results not shown and [22]).
This may lead to compensation by the Na/K-exchangers and
rapid consumption of ATP. At 100 nM CCCP, the ATP levels in
neutrophils incubated without glucose were reduced by about
30%, whereas this concentration did not affect the plasma
membrane potential (results not shown). This suggests only a
partial requirement for Dym in maintaining ATP levels in
neutrophils, since Dym is completely lost at this concentration of
CCCP (not shown). Similarly, the inhibitors KCN (Figure 4E) and
aurovertin B (Figure 4F) decreased ATP levels in neutrophils by
about 30% at concentrations above 100 mM and 100 nM,
respectively. In PBMC, these concentrations were much more
effective, leading to a decrease in ATP to less than 10% of the
normal levels. Apparently, the OXPHOS system only partly
maintains ATP levels in starving neutrophils.
Cells incubated in the presence of glucose seemed almost
impervious to inhibition of the respiratory chain, as indicated by
ATP levels. However, lactate production in both cell types
increased significantly in response to increased levels of the
inhibitors (Figure 5). Even in the absence of glucose (and
inhibitors), neutrophils displayed about five-fold higher lactate
production than PBMC, indicative of the ability of the former cells
to utilize glycogen as an alternative energy source [3]. This may
also explain why ATP levels in intact neutrophils were not as
profoundly affected as in PBMC by mitochondrial inhibition in the
absence of glucose (Figure 4).
In response to inhibition of complex I, II, III and V (F1), the
increase in lactate production in the presence of glucose was
similar for both neutrophils and PBMC, although the starting level
of lactate produced by neutrophils cultured in the presence of
glucose was generally higher (Figure 5). However, in response to
the complex IV inhibitor KCN, PBMC produced significantly
more lactate than did neutrophils, further indicating the strong
dependency on the intact OXPHOS system of the former cells in
contrast to the latter, which are adapted to low levels of complex
IV by shuttling electrons from complex III directly to molecular
oxygen, thereby generating superoxide [7].
Neutrophils acquire their mitochondrial phenotype
during differentiation
HL-60 cells can be differentiated to neutrophil-like cells in 7–
9 days by stimulating the cells with 1.25% DMSO in the culture
Figure 2. Supercomplex organisation of OXPHOS complexes in
PBMC and neutrophils. A–B) Mitochondria isolated from PBMC (A)
and neutrophils (B) were solubilized in digitonin, and 200 mgo f
mitochondrial protein was separated by BN-PAGE. Strips from the first
dimension were excised and used for second dimension SDS-
(12%)PAGE, transferred to PVDF membrane and immuno-detected
with anti-complex I (20 kDa), complex II (30 kDa), complex III (Core 2,
47 kDa), complex IV (COX II, 26 kDa) and complex V (a, 55 kDa) subunit
antibodies. Blots are representative of three independent experiments.
High molecular weight purified proteins were used as molecular mass
markers in the first dimension BN-PAGE: thyroglobulin, 669 kDa; ferritin
monomer, 440 kDa; catalase 232 kDa; lactate dehydrogenase, 140 kDa.
doi:10.1371/journal.pone.0002013.g002
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like morphology and functions. Up to 70% of the cells become
double positive for the neutrophil markers gp91
phox and EMR3
[23], respectively (Figure 6A) while the cells also gain the ability
to produce a respiratory burst after stimulation with formyl-
methionyl-leucyl-phenylalanine (fMLP), the combination of
platelet activating factor (PAF) and fMLP or phorbol myristate
acetate (PMA) (Figure 6B). Before differentiation (Day 0), the
supercomplex organisation in the mitochondria of HL-60 cells is
similar to the organisation found in PBMC (Figure 6C). After
9 days of differentiation, HL-60 cells have lost some of this
organisation. In particular, complex I expression is significantly
reduced in the large 1.5 MDa supercomplex. In the 370 kDa
supercomplex, complex I is no longer detectable while a complex
I spot appears around the same molecular weight as complex II
(,250 kDa). The expression of complex IV is also reduced
during HL-60 differentiation. Especially the large 1.5 MDa
supercomplex displays reduced levels of complex IV after
differentiation. Similarly, expression of complex III is reduced
in differentiated HL-60 cells, especially from the 600 kDa
supercomplex.
While HL-60 cells loose supercomplex organisation, they gain
resistance to the complex-I inhibitor rotenone (Figure 6D) and the
complex-III inhibitor antimycin A (Figure 6E). In the presence of
glucose, both differentiated and undifferentiated HL-60 cells are
resistant to rotenone and antimycin A, but in the absence of
glucose higher concentrations of these inhibitors is required to
affect ATP levels in the differentiated cells than in the
undifferentiated cells (Figures 6D and E). Differentiated HL-60
cells incubated in the presence of glucose respond to inhibitor
titration by producing increasing amounts of lactate, just like
neutrophils.
Neutrophils can maintain Dym by oxidation of glycerol-3-
phosphate
Neutrophils have a relatively high rate of glycolysis, and this
process seems thus to provide all the energy needed for
phagocytosis and the respiratory burst [3]. During this process,
NAD
+ is reduced, requiring NADH to be reoxidised to keep the
glycolytic pathway running. This can be done by either reducing
pyruvate to form lactate, which normally occurs under anaerobic
circumstances, or by reducing dihydroxyacetone phosphate
(DHAP) to form glycerol-3-phosphate (G3P). G3P can diffuse
into the mitochondria, where it is reoxidised to DHAP by
mitochondrial flavin adenine dinucleotide (FAD)-dependent
glycerol phosphate dehydrogenase (mGPD) on the outer surface
Figure 3. Mitochondrial membrane potential in neutrophils and PBMC. A–D) Neutrophils (&,%) and PBMC (N,#) were incubated with (&,
N) or without (%, #) 5 mM glucose. After 2 hours of pre-incubation at 37uC, the cells were incubated for an additional 2 hours in the presence of
various concentrations of respiratory chain enzyme inhibitors. Afterwards, the cells were stained with the fluorescent dye JC-1, and fluorescence in Fl-
1 and Fl-2 was determined with by flowcytometry. The ratio (Fl-2/Fl-1) represents the coupling efficiency (Dym) of the mitochondria as expressed as a
percentage of the control (2 hour incubation without inhibitor). The average initial value for neutrophils was 3.3260.85 (SD) and for PBMC 3.4160.75
(SD). The F0 inhibitor oligomycin (A) and the F1 inhibitor aurovertin B (B) had a protective effect in all cells, demonstrating that reversal of complex V
does not maintain Dym in neutrophils. The complex III inhibitor antimycin A (C) completely reduced Dym in all cells, while the complex-I inhibitor
rotenone (D) did not affect neutrophils cultured with glucose. Data represent the means (6SEM) of five independent experiments performed in
duplicate.
doi:10.1371/journal.pone.0002013.g003
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subsequently transferred to complex III of the respiratory chain via
ubiquinol.
In this respect, the response of both cell types to complex III
inhibition was particularly striking, with a three-fold increase in
lactate production (Figure 5D), as would be expected since the
G3P shuttle delivers electrons directly to complex III. Isolated
mitochondria from neutrophils can be energised by glycerol
phosphate, as demonstrated by staining with tetramethylrhoda-
mine-methylester (TMRM), proving that the mGDP is present
and functional (Figure 7). The Dym generated with glycerol
phosphate as a substrate was significantly higher (P,0.05) than
with the complex I substrates glutamate/malate, the complex II
substrate succinate or in the absence of substrate (Figure 7C).
Discussion
Even though neutrophils retain some activity of the respiratory
chain complexes involved in OXPHOS, the present study shows
that this activity is mostly required to maintain Dym. In PBMC
and HL-60 cells, which have an active respiratory chain and do
depend on OXPHOS activity to maintain their ATP levels, the
respiratory chain is organised in supercomplexes. During differ-
entiation of HL-60 cells to neutrophil-like cells, this supercomplex
organisation is partly lost while the cells gain the metabolic
properties of neutrophils. The inefficiency of neutrophil mito-
chondria to couple Dym to OXPHOS can be explained by a
decreased expression of the respiratory complexes I, III and IV,
and the lack of their ability to assemble into supercomplexes.
Figure 4. ATP levels in neutrophils and PBMC after treatment with respiratory chain inhibitors. A–F) Neutrophils (&,%) and PBMC (N,#)
were incubated with (&, N) or without (%, #) 5 mM glucose. After 2 hours of pre-incubation at 37uC, the cells were incubated for an additional
2 hours in the presence of various concentrations of the mitochondrial uncoupler CCCP (A), or inhibitors for the OXPHOS complexes I-V(F1), rotenone
(B), 3-nitropropionate (3NP; C), antimycin A (D), KCN (E), or aurovertin B (F), repectively. ATP levels were determined with a luciferase-based assay.
Data represent the means (6SEM) of three independent experiments performed in duplicate.
doi:10.1371/journal.pone.0002013.g004
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compared to HL-60 cells and PBMC, a defect that arises during
differentiation [6]. Since most subunits of the respiratory chain
complexes-and all subunits of complex II-are encoded in the
nucleus, but several key proteins are still encoded by mitochon-
drial DNA (mtDNA), a decreased expression of all OXPHOS
complexes except for complex II is not difficult to envision, but the
consequences are far reaching. It has been shown in several
human disorders that a defect in mtDNA leads to a different
composition of the respiratory chain complexes and super-
complexes in skeletal muscle [24,25]. However, assembly and
stability of complex I not only depend on the correct information
in the nuclear and mitochondrial genome, but also on whether
respirasomes can be formed with complex III [26,27]. While fully
assembled complex I has a molecular mass of about 900 kDa,
seven distinct complex I assembly intermediates ranging from 200
to 650 kDa have been identified in patients with complex I
deficiency [28]. In addition, critical amounts of complexes III and
IV are required for respiratory supercomplexes to assemble and to
provide mitochondrial functional complementation [25]. More-
over, the expression of two forms of a supercomplex consisting of
complex III and IV, namely III2IV2 and III2IV1, and free complex
III depends on the growth conditions of the cells [18]. In
neutrophils, only free complex III was demonstrable. The
importance of the remaining complex III is stressed by our finding
that lactate production, while being already high from the
Figure 5. Lactate levels produced by neutrophils and PBMC after treatment with respiratory chain inhibitors. A–F) Neutrophils (&,%)
and PBMC (N,#) were incubated with (&, N) or without (%, #) 5 mM glucose. After 2 hours of pre-incubation at 37uC, the cells were incubated for an
additional 2 hours in the presence of various concentrations of the mitochondrial uncoupler CCCP (A), or inhibitors for the OXPHOS complexes I-
V(F1), rotenone (B), 3-nitropropionate (3NP; C), antimycin A (D), KCN (E), or aurovertin B (F), respectively. Lactate levels were determined with an
enzymatic assay. Data represent the means (6SEM) of three independent experiments performed in duplicate.
doi:10.1371/journal.pone.0002013.g005
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PLoS ONE | www.plosone.org 7 April 2008 | Volume 3 | Issue 4 | e2013Figure 6. HL-60 cells loose supercomplex organisation and acquire neutrophil-like properties during differentiation. HL-60 cells were
differentiated to neutrophil-like cells in 9 days. To demonstrate that HL-60 cells gain a neutrophil-like morphology and abilities during differentiation,
the expression of the neutrophil markers gp91
PHOX and EMR3 was determined by flowcytometry (A) and their ability to produce a respiratory burst
was determined by an Amplex Red assay (B). On day 9 of differentiation, approximately 60% of the cells stained positive for both neutrophil markers,
while responding to all three stimuli (PMA, fMLP and the combination of PAF and fMLP) by producing a respiratory burst. Plots are representative of
four independent experiments. C) Supercomplex organisation in HL-60 mitochondria before (Day 0) and after (Day 9) differentiation. Respiratory
chain complexes were detected on Western blots of 2D-native/reduced SDS-PAGE gels with anti-complex I (20 kDa), complex II (30 kDa), complex III
(Core 2, 47 kDa), complex IV (COX II, 26 kDa) and complex V (a, 55 kDa) subunit antibodies. Blots are representative of four independent experiments.
During differentiation, HL-60 cells gain the metabolic properties of neutrophils (D and E). Undifferentiated (&,%) and differentiated (N,#) HL-60 cells
were incubated with (&, N) or without (%, #) 5 mM glucose. After 2 hours of pre-incubation at 37uC, the cells were incubated for an additional
2 hours in the presence of various concentrations of the complex-I inhibitor rotenone (D) or the complex-III inhibitor antimycin A (E) as indicated.
Afterwards, ATP (left panels) and lactate (right panels) levels were determined. Data represent the means (6SEM) of three independent experiments
performed in duplicate.
doi:10.1371/journal.pone.0002013.g006
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PLoS ONE | www.plosone.org 8 April 2008 | Volume 3 | Issue 4 | e2013beginning, still increases when this complex is inhibited, and the
fact that Dym in neutrophils is lost upon incubation with
antimycin A. Complex IV showed only residual activity in
neutrophils, although very high concentrations of the complex
IV inhibitor KCN ($500 mM) did affect the ATP levels in starved
neutrophils. Complex IV did not form supercomplexes with other
respiratory chain complexes. As a consequence of the minor
activity of complex IV, the electrons that flow from the proximal
end of the respiratory chain will remain in the Q-cycle of complex
III unless they are transferred on a one-to-one basis to molecular
oxygen. While we have shown that the residual components of
respiratory chain are not important for the production of ATP,
maintenance of the Dym in neutrophils will thus be at the cost of a
relatively high mitochondrial superoxide production [7]. The
majority of the required energy is provided by the G3P shuttle via
mGPD as indicated by our finding that inhibition of complex III,
but not so much of complex I or II, leads to a significant increase
in lactate production in neutrophils. This mechanism also explains
the fact that rotenone only affects Dym in neutrophils in the
absence of glucose. Under such starvation conditions, pyruvate
will not be converted to lactate, but its full energy content will be
utilized to produce NADH and FADH2 by which the remainder of
complex I can play a (modest) role in maintaining Dym.
It is quite striking that the PBMC displayed such remarkable
sensitivity for the mitochondrial inhibitors in the absence of
glucose, as far as their ATP levels are concerned. Apparently,
the absence of extracellular glucose is a strong stimulus for
PBMC to utilize their mitochondria for their energy production,
while aerobic glycolysis seems to be inhibited under these
conditions. Starving cells may switch to fatty acid metabolism,
which is completely dependent on mitochondria. As a conse-
quence, the cells become more sensitive to mitochondrial
inhibition, as shown in figures 4 and 5. The ATP levels in
undifferentiated HL-60 cells are affected by starvation alone, as
shown in figure 6D and E. Apparently, these cells are not
selected for the ability to use substrates other than glucose very
efficiently. On the other hand, starvation alone is not sufficient
to affect the ATP levels in the differentiated cells. This might
Figure 7. Membrane potential of isolated neutrophil mitochondria. Isolated neutrophil mitochondria were analysed by flow cytometry after
staining with Mitotracker Green, to differentiate intact mitochondria from cellular debris, and TMRM to determine Dym. A) Scatter plot displaying
intact mitochondria, defined as Mitotracker-Green-positive events (FITC channel) with high side scatter in Q2. B) Intact mitochondria gained TMRM
staining (Dym, PE channel) after incubation with mitochondrial substrates. The complex-I substrates glutamate/malate (green) and the complex-II
substrate succinate (yellow) induced a lower Dym than glycerol phosphate (blue). Graphs are representative of three independent experiments. C)
Graphic representation of the pooled experiments. Relative Dym is expressed as a percentage of the mean fluorescence intensity (MFI) in the PE
channel of the mitochondria population (Q2 in Figure 7A). The MFI of glycerol phosphate (GlycP) treated mitochondria was set at 100% while the
MFIs of the untreated (C-), glutamate/malate (Glut/Mal) and succinate (Succ) treated cells were expressed as a percentage of this value. The average
original value for C- was 17016498 (SEM), for Glut/Mal 444262689 (SEM), for Succ 548163106 (SEM) and for GlycP 583863139 (SEM). Bars represent
the means (6SEM) of three independent experiments.
doi:10.1371/journal.pone.0002013.g007
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the form of glycogen.
Complex I was not detectable on the BN/SDS-PAGE of
neutrophil mitochondria (Figure 2B), but only on a (denaturating)
Western blot (Figure 1C). Its protein expression was estimated to
be only about 1% of that present in HL-60 cells and about 6% of
that in PBMC. In the latter two cell types, complex I apparently
assembles into two supercomplex forms, of about 1.5 MDa with
complex III and IV, and of about 370 kDa with complex IV only
(Figures 2A and 6C). Since a fully assembled complex I has an
apparent molecular mass of about 900 kDa, the smaller super-
complex in HL-60 and PBMC must, therefore, contain an
assembly intermediate of complex I as found in complex-I-
deficient patients [28]. The subcomplex II is a likely candidate,
since it contains the subunit NDUFS7 of 20 kDa to which the
reference antibody was directed (Figures 2A and 6C) and has the
proper apparent molecular mass of 230 kDa. We seem to detect
this assembly intermediate around 230 kDa in differentiated HL-
60 cells (Figure 6C), where it is not associated with either complex
III or complex IV.
In neutrophils, the activity of complex V was comparable to that
in PBMC and HL-60 cells, but its relative protein expression is
50% less than in PBMC and about 3-fold less than in the myeloid
precursor HL-60. Besides the monomeric (,600 kDa) and dimeric
(,1.5 MDa) forms, various subcomplexes of complex V were
detected (Figure 2) including the assembly intermediates of about
370 and 470 kDa in the three cell types under study, and even
smaller complexes still containing subunit a in PBMC and HL-60
cells. Such subcomplexes of complex V are indicative for
mitochondrial biosynthesis disorders [13]. In that respect,
neutrophils in particular resemble the mitochondrial DNA
depletion syndrome [24], in accordance with the low mtDNA
copy number found earlier by us [6]. In such patients,
subcomplexes of complex V lack the F0-subunit [13]. This
generally leads to less efficient coupling of respiration to ADP
phosphorylation [13,24]. Recent evidence indicates that complex
V has a strong influence on the shape and architecture of the
mitochondria due to its size and the tendency of F0 to form dimers
in the mitochondrial membrane [29,30]. A decreased expression
of such dimers in neutrophil mitochondria might explain the
peculiar tubular shape of these mitochondria [6,7], and their
inability to couple Dym to ATP synthesis.
In summary, we show for the first time that the Dym in
neutrophils is maintained by complex III of the respiratory chain
in the absence of detectable complex IV activity and not by
complex V, as has been suggested for eosinophils [31]. This
complex III activity does not contribute significantly to the energy
status of the cells, while the energy for maintaining Dym is mainly
derived from the G3P shuttle (Figure 7). Thus, the role of
neutrophil mitochondria is not restricted to apoptosis, but is also
important in the regulation of glycolysis. Neutrophil mitochondria
do not contain respirasomes and, as a consequence, they do not
couple Dym to efficient respiration and ATP synthesis. This
particular phenotype probably arises during maturation from
myeloid precursor cells, since we found that the mitochondria
from HL-60 cells do contain respirasomes, while they loose some
supercomplex organisation during differentiation to a neutrophil-
like phenotype (Figure 6). These findings demonstrate the diversity
of mitochondrial organisation within the human organism, and the
implications of this organisation for cellular functions. In addition,
they provide insight in the nature and consequences of
mitochondrial biosynthesis disorders as well as indicating neutro-
phils as a model system for these disorders. The implications of
these findings for neutrophil survival warrant further investigation.
Materials and Methods
Primary cell isolation and culture
Neutrophils and PBMC were isolated from heparinised blood of
healthy volunteers, after informed consent had been obtained, by
density gradient centrifugation over isotonic Percoll (Pharmacia,
Uppsala, Sweden) and erythrocyte lysis [32]. PBMC were defined
as the cells in the interface above the Percoll layer. Cells were
cultured in Hepes-buffered saline solution (HBSS, 132 mM NaCl,
20 mM Hepes, 6 mM KCl, 1 mM MgSO4, 1.2 mM K2HPO4,
1 mM CaCl2, pH 7.4; chemicals from Merck) at a concentration
of 10
7 cells/mL in polypropylene round-bottom tubes of 14 mL
(Falcon; BD; Franklin Lakes, NJ, USA). The medium was
supplemented with 5 mM glucose where indicated. The incuba-
tion volume was never larger than 2.5 mL. All incubations were
performed in a shaking water bath at 37uC.
Culture and differentiation of HL-60 cells
HL-60 cells were cultured in Iscove’s modified Dulbecco’s
medium (BioWhittaker, Brussels, Belgium) supplemented with
10% heat-inactivated foetal calf serum (Gibco BRL, Paisley,
United Kingdom), 100 IU/mL penicillin (Gibco BRL), 100 mg/
mL streptomycin (Gibco BRL), 300 mg/mL L-glutamine (Gibco
BRL) and 50 mM b-mercaptoethanol (Gibco BRL), at 37uC, 10%
CO2, until use.
Cells were differentiated in the same medium, supplemented
with 1.25% dimethyl sulfoxide (DMSO; J.T. Baker BV, Deventer,
The Netherlands) at a concentration of 0.5*10
6 cells/mL. Every
other day, the cells were counted and diluted to 0.5*10
6 cells/mL
in IMDM+1.25% DMSO. On day 0 and 9 of the differentiation
the cells were harvested. To determine the differentiation state,
cells were tested for the expression of the neutrophil markers
EMR3 (clone 3D7, biotinylated F(ab’)2 fragments, a kind gift from
Dr. J. Hamann at the Academic Medical Centre in Amsterdam,
The Netherlands [23]) and gp91
phox (clone 7D5, Sanquin,
Amsterdam, The Netherlands). Labelling was performed in HBSS
on ice for 20 minutes with the primary antibodies, after which the
cells were washed and incubated with APC-labelled streptavidin
(BD) to detect EMR3 and Alex Fluor-488-labelled goat-anti-
mouse-IgG (Molecular Probes, Eugene, OR, USA) to detect
gp91
phox. Fluorescence was detected with an LSRII flowcytometer
(BD). Quadrant settings were based on the background staining of
non-differentiated cells. In addition, morphology of the cells was
routinely checked by microscopy of cytospins stained with May-
Gru ¨nwald-Giemsa stain.
NADPH-oxidase Activity
Activity of the NADPH-oxidase in differentiated HL-60 cells
was determined with an Amplex Red assay (Molecular Probes)
after stimulation with 1 mM fMLP, the combination of 1 mM
fMLP and 1 mM PAF, added simultaneously, or 100 ng/mL
PMA, as described [33].
Isolation of Mitochondria and Oxidative Phosphorylation
Enzyme Activities
Cells were resuspended at a concentration of 5 mg/mL protein
in mito buffer (0.2 mM EDTA, 0.25 mM sucrose, 10 mM
Tris.HCl, pH 7.8) supplemented with a protease inhibitor mixture
(PIM) of two Complete tablets per 50 mL (Roche Diagnostics,
Almere, The Netherlands), 1 mM 4-(2-aminoethyl)-benzenesulfo-
nyl-fluoride hydrochloride (Pefabloc SC, Roche) and 2 mM
diisopropyl fluorophosphate (DFP; Fluka Chemica, Steinheim,
Switzerland), freeze/thawed in liquid nitrogen and, after the
addition of 10 mM triethanolamine and 0.1 mg/mL digitonin,
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Teflon Potter-Elvehjem homogenizer, and centrifuged at 1000xg
for 10 min at 4uC. The supernatant was saved, the pellet
resuspended in the same volume of mito buffer supplemented
with 0.1 mg/mL digitonin, homogenised and centrifuged once
again. The combined supernatants were centrifuged at 12000xg
for 15 min at 4uC, and the mitochondria-rich pellet was
resuspended in mito buffer at the desired protein concentration.
OXPHOS complexes were determined according to Birch-
Machin & Turnbull [34] with some essential modifications. The
spectrophotometric methods were scaled down by the use of sub
microcell quartz cuvettes (Hellma GmbH, Mu ¨llheim, Germany) of
100 mL, by which the concentration of cells could be increased
without requiring large amounts of blood. Complex I activity was
determined as the rotenone-sensitive oxidation of NADH with
ubiquinone1 as electron acceptor (100 mM final concentration) at
340 nm, with 380 nm as the reference wavelength [35]. To assess
complex II activity the extinction difference between 600 and
520 nm was used to follow the ubiquinone2-coupled TTFA-
sensitive reduction of 2,6-dichlorophenolindophenol, with succi-
nate as the substrate. Complex III was measured as the change in
extinction difference between 550 and 540 nm for the antimycin-
A-sensitive reduction of cytochrome c by ubiquinol2. Complex IV
was determined by following the oxidation of reduced cytochrome
c at 550 nm, with 540 nm as the reference wavelength in the
presence of n-dodecyl-b-D-maltoside. Complex V was measured
as oligomycin-sensitive Mg-ATPase activity immediately after
brief sonication of the neutrophils according to Rustin et al. [36].
All inhibitors and substrates were obtained from Sigma (St. Louis,
MO, USA).
The OXPHOS complex activities were expressed per mg
protein as determined by the Bio-Rad DC protein assay (Bio-Rad
Laboratories, Inc., Veenendaal, The Netherlands) with BSA as a
standard, or normalized to the activity of citrate synthase
determined according to Srere [37]. All assays were performed
at least in duplicate.
Blue-Native PAGE and Western-blotting
Mitochondria were incubated in lysis buffer (50 mM NaCl,
5 mM aminocaproic acid, 50 mM imidazole, pH 7.0) supple-
mented with PIM and digitonin (4 g/g mitochondrial protein) for
10 min on ice, and 200 mg of mitochondrial protein was further
processed for first dimension BN-PAGE according to Scha ¨gger
[38] on a 5–13% acrylamide gradient gel. Strips from the first
dimension BN-PAGE were then excised, reduced for one hour at
room temperature in 1% SDS containing 4 mL/mL tributylpho-
sphine, and used for second dimension SDS-(12%)PAGE.
Western blotting was performed in a fully submerged Mini
Trans-blot system (Bio Rad) using CAPS buffer (10 mM 3-
[cyclohexylamino]-1-propane sulfonic acid, pH 11, 10% metha-
nol) on PVDF membrane, after which the cornerstone subunit of
each of the five OXPHOS complexes were visualized with the
OXPHOS Western blotting kit (MS601; Mitosciences), biotiny-
lated anti-mouse IgG (RPN1001, Amersham Biosciences), strep-
tavidin-biotinylated horseradish peroxidase complex (RPN1051;
Amersham) and SuperSignal West Femto (Pierce). Images were
acquired using a calibrated densitometer (GS-800; Bio-Rad) and
the PDQuest software package (version 6.2.1; Bio-Rad).
Determination of Dym
To assess Dym in neutrophils and PBMC, cells were incubated
at 10
7 cells/mL in HBSS with or without 5 mM glucose. After
2 hours of pre-incubation at 37uC the cells were incubated for an
additional 2 hours in the presence of various concentrations of the
indicated inhibitors in a shaking incubator. All inhibitors were
obtained from Sigma and dissolved in dimethyl sulfoxide (DMSO).
The total amount of DMSO added to the cells was 1% (v/v) for all
incubations.
After incubation, the cells were stained by addition of 0.5 mMo f
the fluorescent dye JC-1 (all probes from Molecular Probes,
Eugene, OR, USA) for an additional 15 minutes at 37uC. To
determine a background value for Dym, cells were incubated with
1 mM CCCP (Calbiochem, La Jolla, CA, USA), which is sufficient
to completely abrogate Dym. Red (Fl-2) and green (Fl-1)
fluorescence was subsequently determined on a BD FACScan
flowcytometer. The red-to-green ratio was determined by dividing
the geometric mean fluorescence in Fl-2 by that in Fl-1. This value
was corrected by subtracting the value obtained from the CCCP
incubation and expressed as a percentage of the DMSO control.
All assays were performed in duplicate.
ATP and lactate assays
Incubation conditions were the same as mentioned above for
Dym determination. After incubation, the cells were lysed by the
addition of 1.5% HClO4 for 10 minutes on ice. After centrifuga-
tion the supernatant was neutralized with an equimolar amount of
K2CO3. Insoluble KClO4 was precipitated by quick centrifugation
and the supernatant was stored at 280uC.
ATP levels were determined by adding 100 mL of the firefly
luciferase based adenosine 59-triphosphate (ATP) assay mix
(Sigma) diluted 1:10 in ATP-assay buffer (5 mM MgSO4,
100 mM EDTA, 100 mM NaN3, 4 mM DTT [DL-dithiothreitol,
Sigma], in 25 mM TrisHCl, pH 7.8) to 10 mL of the supernatant
of the neutralized lysate in a white 96-well plate (Corning Life
Sciences, Corning, NY, USA). Samples were compared with an
ATP standard (Sigma) treated in the same way as the samples.
Luminescence intensity was determined immediately on a Spectra
Fluor Plus spectrophotometer (Tecan, Zu ¨rich, Switzerland).
To determine lactate levels produced by the cells, 20 mL of the
supernatant of the neutralized lysate was mixed with 100 mLo f
lactate assay solution (Trinity Biotech plc, Wicklow, Ireland). After
15 minutes of incubation at room temperature, absorbance was
measured at 540 nm in the spectrophotometer.
Analysis of Dym in isolated mitochondria
The mitochondrial fraction from ,150*10
6 neutrophils was
resuspended in 2 mL of mitochondria assay buffer (120 mM KCl,
5m MK H 2PO4, 1 mM EDTA, 1 mM MgCl2, 3 mM Hepes,
pH 7.8, 1% (v/v) human serum albumin; Sanquin, Amsterdam,
The Netherlands) and divided in 100-mL portions that were either
left unsupplemented or supplemented with either 10 mM sn-
glycerol 3-phosphate, the combination of 10 mM glutamate and
2 mM malate, or 10 mM succinate.
After 1 hour of incubation at 37uC, the mitochondria were
stained for an additional 15 minutes with 1 mM Mitotracker
Green, to differentiate intact mitochondria from cellular debris,
and 100 nM TMRM to determine Dym. Samples were analysed
on a LSRII flow cytometer (BD) with FACSDiva software. To
detect small particles, forward scatter (FSC) was set to 600 and side
scatter (SSC) to 550. Intact mitochondria were defined as having
high side scatter (SSC) and high Mitotracker staining (FITC
channel). Compensation between PE and FITC was set at 15%. At
least 10,000 positive events were collected for each sample. All
assays were performed in duplicate.
Statistical analysis and image processing
Graphs were drawn and statistical analysis was performed with
Prism 4.03 (GraphPad Software). The results are presented as the
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one-tailed student’s t-test, where indicated. The criterion for
significance was P,0.05 for all comparisons.
Images were processed in Adobe Photoshop CS (Adobe Systems
Inc.) and CorelDRAW 11 (Corel Corporation).
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